Literature DB >> 10576483

Corticomotor excitability and perception of effort during sustained exercise in the chronic fatigue syndrome.

P Sacco1, P A Hope, G W Thickbroom, M L Byrnes, F L Mastaglia.   

Abstract

OBJECTIVE: We have investigated the possibility of a central basis for the complaints of fatigue and poor exercise tolerance in subjects with chronic fatigue syndrome (CFS).
METHODS: Transcranial magnetic stimulation of the motor cortex was used to measure sequential changes in motor evoked potential (MEP) amplitude, post-excitatory silent period (SP) duration and twitch force of the biceps brachii muscle during a 20% maximum isometric elbow flexor contraction maintained to the point of exhaustion. Ten patients with post-infectious CFS and 10 age- and sex-matched control subjects were studied. Results were analysed using non-parametric repeated measures analysis of variance (Friedman's test) and Mann-Whitney U-tests for intra- and inter-group comparisons respectively.
RESULTS: Mean endurance time for the CFS group was lower (13.1+/-3.2 min, mean +/- SEM) than controls (18.6+/-2.6 min, P < 0.05) and CFS subjects reported higher ratings of perceived exertion. During the exercise period MEP amplitude and SP duration increased in both groups but to a lesser extent in CFS subjects. Interpolated twitch force amplitude also increased during exercise, being more pronounced in CFS subjects.
CONCLUSION: The findings are in keeping with an exercise-related diminution in central motor drive in association with an increased perception of effort in CFS.

Entities:  

Mesh:

Year:  1999        PMID: 10576483     DOI: 10.1016/s1388-2457(99)00144-3

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  9 in total

Review 1.  Evidence for complex system integration and dynamic neural regulation of skeletal muscle recruitment during exercise in humans.

Authors:  A St Clair Gibson; T D Noakes
Journal:  Br J Sports Med       Date:  2004-12       Impact factor: 13.800

2.  Cortical voluntary activation testing methodology impacts central fatigue.

Authors:  José Mira; Thomas Lapole; Robin Souron; Laurent Messonnier; Guillaume Y Millet; Thomas Rupp
Journal:  Eur J Appl Physiol       Date:  2017-07-07       Impact factor: 3.078

Review 3.  Endurance time is joint-specific: a modelling and meta-analysis investigation.

Authors:  Laura A Frey Law; Keith G Avin
Journal:  Ergonomics       Date:  2010-01       Impact factor: 2.778

4.  Prior physical exertion modulates allocentric distance perception: a demonstration of task-irrelevant cross-modal transfer.

Authors:  Ella V Clark; Nick S Ward; Annapoorna Kuppuswamy
Journal:  Exp Brain Res       Date:  2016-04-06       Impact factor: 1.972

Review 5.  Understanding neuromuscular disorders in chronic fatigue syndrome.

Authors:  Yves Jammes; Frédérique Retornaz
Journal:  F1000Res       Date:  2019-11-28

6.  Cardiopulmonary, metabolic, and perceptual responses during exercise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Multi-site Clinical Assessment of ME/CFS (MCAM) sub-study.

Authors:  Dane B Cook; Stephanie VanRiper; Ryan J Dougherty; Jacob B Lindheimer; Michael J Falvo; Yang Chen; Jin-Mann S Lin; Elizabeth R Unger
Journal:  PLoS One       Date:  2022-03-15       Impact factor: 3.240

7.  Muscle fatigability and post-acute COVID-19 syndrome: A case study.

Authors:  Jacob Fanous; Alexander M Zero; Charles L Rice
Journal:  Physiol Rep       Date:  2022-08

8.  Resting and active motor thresholds versus stimulus-response curves to determine transcranial magnetic stimulation intensity in quadriceps femoris.

Authors:  John Temesi; Mathieu Gruet; Thomas Rupp; Samuel Verges; Guillaume Y Millet
Journal:  J Neuroeng Rehabil       Date:  2014-03-21       Impact factor: 4.262

Review 9.  Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics.

Authors:  Gerwyn Morris; Michael Maes
Journal:  BMC Med       Date:  2013-09-17       Impact factor: 8.775

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.